Public Company

Natco Pharma receives the cancer drug boost

Natco Pharma touched a high of Rs 134 and a low of Rs 124. The stock finally ended with a 5.2% at Rs 129. Around 2.96 lakh shares were traded on the BSE as against the two-week average trade of 1.06 lakh shares. __________________________________________________ UCO Bank seeks shareholders" nod for fund raising Negative view on state-run oil cos: Fitch Jan cement sales in high double-digit The government stayed the Drug Controller of India order suspending the drug for not passing the test measuring endotoxin levels. Albupax is a nanatechnology-based drug. It consists of paclitaxel in an Albumin-bound nanoparticle form and is used in the treatment of breast cancer.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
Sun Pharma net profit dips 11.5%
Sun Pharmaceutical Industries, India’s largest drug firm in terms of market capitalisation, posted a 11.49 dip in net profit during the quarter ended September 30, compared with the same period last year, due to regulatory issues and the resultant loss of revenue for its US subsidiary, Caraco Pharmaceuticals.
Popular Articles
payday loans online

Leisure properties report 'sell-out'
The robust bookings are in spite of travel advisories issued by Western and pacific countries.
Polygraphy
TextileMin to infuse Rs 1,600 cr into Cotton Corp
The Ministry of Textiles, Government of India is planning to infused additional capital of over Rs 1,600 crore to Cotton Corporation of India (CCI). The Ministry also set a target to inaugurate seven mills which are moderinised at the outlay of Rs 130 crore in the next 100 days.

© Copyright 2009